SOX4 and lung carcinoma: The attractivity of SOX family members for T-cell-based immunotherapy of tumours was documented by a recent report indicating that SOX4 is overexpressed in lung carcinoma and can serve as a target structure of CTLs (Friedman et al, 2004).